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Introduction 
Spinal cord injury is a major catastrophy with no solutions for cure, and realistic expectations 
and possibilities for spinal cord repair are being acknowledged recently.  The incidence of 
spinal cord injuries is approximately 30 per million. The incidence of spinal cord injuries is 
highest in the age group of 16 to 30 years.  More than 80% of spinal cord injury occurs in 
males
1
. Unfortunately most of the victims are young, in the prime of life, left with permanent 
paralysis of limbs, bladder, bowel and sexual functions. This results in far reaching social, 
vocational and psychological consequences. Prevention of complications, stabilisation of 
spine and active rehabilitation and long term follow up constitute the mainstay of the 
management of persons with spinal cord injury. Early rehabilitation in an organised 
multidisciplinary SCI team has been shown to be beneficial with lower mortality, decreased 
pressure sores, and slightly greater chance of neurological recovery and shorter lengths of 
stay in the hospital
2
. Surgical stabilisation helps in early mobilisation, but there are no 
significant differences in neurological level changes between early surgery, late surgery and 
no surgery
3
. There was no evidence that routine early surgical intervention or decompression 
improved neurological outcomes
4
. The national spinal cord injury study NASCIS trials I, II, 
and III on early steroids to limit cellular damage from secondary injury processes suggested 
this to be part of the early management of SCI. The conclusions of this study have been 
challenged due to a variety of reasons
5
.   
Rehabilitation focuses on functional restoration, capitalising on the residual abilities assisted 
with devices and equipment. Devices like specialised light weight wheel chairs and orthotic 
support are commonly used to aid in ambulation. Functional electrical stimulation is used in a 
variety of neuroprosthesis to substitute for different functions lke gait training.                
Sacral anterior root stimulator is used to improve functions of bladder, bowel and sexual 
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function. Body weight support treadmill training could be useful for incomplete injuries. 
Robotic devices, and development in neuroprosthesis facilitate movement and compensates 
for the loss of function. Drugs like monosialo tetra hexosyl ganglioside (GM Ganglioside), 
anti Nogo antibody,  omega poly unsaturated fatty acids have shown good results in the 
experimental spinal cord injury settings. 4 aminopyridine, a potassium channel blocker 
enhances the axonal conduction of demyelinated fibres but with equivocal results on clinical 
study
6
.  
The organisation of spinal cord is unique in that unlike brain the grey matter is located in the 
centre, and the white matter arranged in the periphery. Spinal cord functions are organised 
into functional segments grossly. The lesion to grey matter at a spinal cord segment damages 
the function of that particular segment of the spinal cord, where as the damage to the segment 
of white matter damages the long tracts which ascend to or descend from the brain, affecting 
the functions of the body below the level of the segment of injury.  The common strategies 
for the regeneration of damaged spinal cord include methods to prevent progression of 
secondary injury, provide agents to promote remyelination, remove natural inhibitors of 
regeneration, provide guidance to direct  axons to their target, creation of bridges to promote 
scaffolds which facilitates axonal growth, or replace lost cells . Stem cell transplantation is 
used to replace lost cells, but could also play additional role including delivery of molecules 
that promote regeneration, immunomodulation, enzymatic break down of inhibitory scars, 
reprogramming of endogenous stem cells, elimination of cellular debris and inhibitory 
substances, creation of novel bridges and matrix, and improvement in vasculature to facilitate 
recovery. Stem cells derived from the recipients themselves have the advantage of being 
naturally compatible without any immunological conflicts, thus avoiding need for immuno-
suppression
7
.  
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Stem cells have several characteristics that make them unique in comparison with other cells. 
They exist as unspecialized cells and maintain undifferentiated phenotype until they receive 
appropriate signals. They have capacity for extensive self-renewal and this property can be 
utilized by culturing large number of stem cells in vitro for therapeutic use. Under the 
influence of specific biological signals they differentiate into specialized cells with a 
phenotype which is distinct from its precursor
8
. Thus the definition of a stem cell must 
include two essential characteristics, self-renewal and multipotency. Undifferentiated cells 
that are found in a differentiated adult tissue are considered as stem cells, which contribute to 
tissue maintenance and repair. These cells are capable of self-renewal but do not replicate 
indefinitely in culture. Adult stem cells may differentiate to produce progenitor, precursor 
and mature cells, but these activities are limited to cells contained in a tissue of origin. Adult 
stem cells usually comprise a small minority of the total tissue mass and as such are quite 
difficult to identify and isolate. The concept of stem cell plasticity refers to the phenomenon 
of trans differentiation which is the ability of an adult stem cell from one tissue to 
differentiate as specialized cell type of another tissue
9
. Bone marrow is a source for 
hematopoietic cells as well as non-hematopoietic  mesenchymal stromal/stem cells (MSCs).  
Mesenchymal stem cells are multipotent, self-renewing, that can differentiate into 
osteoblasts, chondrocyte and adipocytes. Bone marrow derived mesenchymal stromal cells, is 
autologous, easily obtainable, can be expanded quickly and can also be differentiated into 
neural cell types in vitro and in vivo.  It was observed that transplanted MSC into a spinal 
cord lesion site enhance axonal regeneration and promote functional recovery in animal 
models. In addition, it is believed that MSCs lack B7 co stimulatory molecules, CD80 , CD86 
and are non immunogenic upon allogenic transplantation.  The overall effect of MSC is to 
rescue neuronal cells by neuro protection, immune modulation, and possibly    re myelination 
and neuro regeneration.  MSC have greatly increased the hope to treat the untreatable central 
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nervous system injuries by meeting these requirements.  Human mesenchymal stem cells are 
isolated from the bone marrow aspirate. They represent a very minor fraction (0.0001%) of 
the total nucleated cell population in marrow, but can be plated and enriched using standard 
cell culture techniques. 
In this study the role of bone marrow stromal cells for restoration of motor control was 
observed in rat models of spinal cord injury. Different doses of cells were delivered to the 
spinal cord injured rats and were followed up to determine the effect of these cells in motor 
recovery. The responses were observed by assessing the behavioural motor scale as well as 
electrophysiologically  by recording the electromyogram from the lower limb muscles of the 
rats following trans cranial stimulation of the motor cortex. 
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Aim :  
 To study the effect of Bone marrow Mesenchymal Stem Cell transplantation for motor 
recovery in rat models of spinal cord injury. 
 
Objectives: 
1.Bone marrow mesenchymal stem cell (MSC)culture and characterization . 
2. Transdifferentiation of MSC  to neuronal cells. 
3.MSC  transplantation to  injured spinal cord segment of rat models. 
4. Outcome assessment  of transplantation  by BBB scale, and EMG. 
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Review of Literature 
Since time immemorial spinal cord injury was synonymous with morbidity and despair. 
Physicians were unable to successfully manage the cascade of interrelated problems and 
complications following spinal cord injury.  Since last few decades spinal cord injury has 
been considered a manageable condition, compatible with reasonably good health with near 
normal life expectancy. Despite landmark achievements in medical field during the 
nineteenth century, such as Pasteur’s discoveries in bacteriology, Lister’s aseptic techniques, 
Roentgen’s discovery of X rays and introduction of anaesthesia, management of spinal cord 
injury was poorly organised with grave outcome.. Sir Ludwig Guttman introduced the 
comprehensive care and interdisciplinary rehabilitation of persons with spinal cord injury, a 
model which has been widely replicated around the world. The success of specific units 
highlighted the fact that inadequate training, experience, number of staff, facilities, and 
equipment, not only placed the spinal cord injured person’s life at risk, but often resulted in 
development of complications and poor functional outcomes.  
Life expectancy of persons with spinal cord injuries has increased steadily over decades, but 
still remains below the able bodied individuals. Predictors of mortality include age, male sex, 
being complete injury, high neurological level, emotional distress, functional dependency, 
and poor adjustment to disability
10
.  
The motor system performs many different tasks, reflex and voluntary, with speed and 
accuracy because of two special features of the organisation. First, the processing of the 
sensory inputs and the commands to the motor neurons and muscles is hierarchically 
interconnected in areas of spinal cord, brainstem and forebrain. Each level has circuits that 
can organise or regulate complex motor responses through their output and input connections. 
Second, sensory information relating to the movement is processed in different systems that 
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operate in parallel. The spinal cord is the lowest level of this hierarchical organisation. It 
contains the neuronal circuits that moderate a variety of reflexes and rhythmic activities such 
as locomotion. The simplest normal circuit is monosynaptic. It includes only the primary 
sensory neuron and the motor neuron. Most reflexes are mediated by polysynaptic circuits 
where one or more inter neurons are interposed between primary sensory neuron and the 
motor neuron. Inter neurons and motor neurons also receive input from axons descending 
from higher centres. These supra spinal signals can modify reflex responses to peripheral 
stimuli by facilitating or inhibiting different populations of inter neurons. They also 
coordinate motor actions through these inter neurons. For example, when a joint is flexed, the 
descending commands that drive the flexor muscles also inhibit the opposing extensor 
muscle. All motor commands eventually converge on motor neurons whose axons exit the 
spinal cord to enervate the skeletal muscles. Thus motor neuron forms the final common 
pathway for all motor actions. By facilitating some circuits and inhibiting others, higher 
levels can let sensory input govern the temporal details of the evolving movement. The 
timing of activities of agonist and antagonist muscles is intrinsic to the spinal circuit and thus 
descending signals themselves need not be timed precisely. The patterns of coordination in 
spinal cord are relatively stereotyped. A cat with its cervical cord transacted can if provided 
with body support, walk in a moving treadmill and bring its paw around an obstacle after 
hitting it. But the spinal cat cannot lift its fore limb before impact with an obstacle an intact 
animal does, because this movement requires controlling of limbs using visual information
11
.  
At the spinal cord level, afferent impulses produce simple reflex responses. At higher levels 
in the nervous system, neural connections of increasing complexity mediate increasingly 
complex motor responses. In the intact animal, individual motor responses are integrated into 
the total pattern of motor activity. When the neural axis is transected the activities integrated 
below the level of section are released from the control of higher brain centres. This could be 
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due to removal of inhibitory control from higher centres or due to denervation 
hypersensitivity of centres below the level of transaction. 
External anatomy: In adults, spinal cord extends from the medulla oblongata at the base of 
the brain to the lower border of the first lumbar vertebra. Spinal cord is enclosed in the bony 
vertebral canal, covered by three layers of connective tissue called meninges the pia, 
arachnoid and dura mater, and protected by cerebrospinal fluid to buffer the cord against any 
traumatic damage. The accepted definition of spinal instability by White and Punjabi is 
clinical instability where there is a loss of ability of the spine under physiological loads to 
maintain relationship between vertebrae in such a way that there is no damage to spinal cord 
or nerve roots
12
.  
The arrangement of the spinal cord appears to be segmental. 31 pairs of spinal nerves emerge 
at regular intervals thorough intervertebral foramen. Each pair of spinal nerves arise from the 
corresponding spinal segment, Spinal nerves are paths of communication between spinal cord 
and the specific end organ in the body. Two bundles of axons called the roots of the nerve 
connect each spinal nerve to the corresponding segment of the cord.  The posterior root 
contains only sensory axons which conduct nerve impulses from the sensory receptors in the 
skin, muscles and internal organs to the central nervous system. The posterior root has a 
swelling at the intervertebral foramen known as the dorsal root ganglion which contain the 
cell bodies of the sensory neurons. The anterior or ventral root contain axons of motor 
neurons which conduct nerve impulses from spinal cord to muscles and effector organs.  
Internal Anatomy; The anterior median fissure and the posterior median sulcus divide the 
cord into two sides. The grey matter is arranged like the letter H surrounded by the white 
matter. The grey matter contains primarily of cell bodies of neurons, neuroglia and           
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inter neurons. The white matter consists of bundles of myelinated and unmyelinated axons of 
sensory and motor neurons.  
 
Internal anatomy of spinal cord: 
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The gray matter on each side of the spinal cord is divided into regions called horns. The 
anterior or ventral horn contains cell bodies of somatic motor neurons and which enervate 
skeletal muscles. The posterior or dorsal gray horn contains somatic sensory nerve cell 
bodies. Between the anterior and the posterior gray horns are the lateral gray horns which 
contain the cell bodies of the autonomic sympathetic neurons which regulate the activities of 
heart, smooth muscles and glands. The white matter is also arranged into three broad areas 
called the columns: anterior/ventral white column, posterior/dorsal column, and the lateral 
column. Each column contains distinct bundles of axons known as tracts. Axons that conduct 
the impulses towards the brain are the ascending tracts or sensory tracts, and those that 
conduct impulse down the spinal cord from the higher centres are known as the descending 
tracts. Nerve impulses from sensory receptors propagate up the spinal cord to brain along two 
main routes on each side. The lateral and anterior spinothalamic tracts convey impulses for 
sensing pain and temperature. The posterior columns of either side convey touch and 
proprioception.   Cerebral cortex plays a crucial role in precise voluntary muscular movement 
control. Motor output travel down the spinal cord along two descending pathways, direct and 
indirect. The direct pathways include lateral and anterior cortico spinal and cortico bulbar 
tracts. They cause precise voluntary movements of the skeletal muscle. The indirect pathways 
include rubrospinal, tectospinal and vestibulospinal tracts. They control automatic and 
coordinating movements of the body and maintain muscle tone and equilibrium.  
The corticospinal neuron is clinically known by the term upper motor neuron. This synapses 
with the lower motor neurons which in turn synapse with the muscles. Damage to spinal cord 
causing lesion in the axons of the upper motor neuron results in a constellation of signs and 
symptoms called the upper motor neuron syndrome. This includes loss of motor control, 
spasticity, hyper reflexia, clonus and Babinskis sign. The damage to lower motor neuron in 
the central gray matter of the spinal cord leads to lower motor neuron signs like loss of 
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muscle tone or hypotonia,  hyporeflexia, ie loss of tendon reflexes, and gross muscle wasting. 
Following an acute spinal cord injury, spinal cord shows a period of spinal shock, a transient 
suppression and gradual return of reflexes. 
Spinal cord is supplied by a single anterior spinal artery and two posterior spinal arteries. 
This is replenished by several radicular segmental arteries. Posterior spinal artery is a branch 
of vertebral artery and supplies posterior one third of the spinal cord. The anterior spinal 
artery also a branch of the vertebral artery supplies the anterior two third of the spinal cord. 
The areas at T1 to T4 and T12 to L2 form the water shed regions and particularly prone to 
ischemic damage. Due to the dual posterior and single anterior blood supply, ischemia often 
affects the anterior part of the cord known as the anterior cord syndrome, with motor loss, 
loss of pain and temperature, but preserved touch and position sensation. 
Pathology: The secondary injury cascade causes further neuronal damage due to  the 
biochemical changes. Ischaemia of gray matter due to vasoconstriction mediated by 
vasoactive substances like serotonin, thromboxanes, platelet activating factor, is followed by 
oedema at the site of injury. There is rise of intracellular calcium, rise in exitotoxic  
aminoacids such as  glutamate and aspartate. Intra cellular calcium facilitates activation of 
phospholipases, production of free radicals and free fatty acid metabolites which cause 
damage to cell membrane. This releases potassium and its level rises in the extra cellular 
space leading to conduction block. Micro haemorrhages appear in this area of damage. Iron 
from this  haemorrhage catalyses the per oxidation of lipids, leading to further tissue damage.  
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Schematic diagram of spinal cord pathology following trauma 
 
This leads to the formation of central cavity surrounded by astrocytic scar with a small rim of 
white matter with demyelinated axons in the periphery of the spinal cord 
Neutrophils migrate to the site of injury which releases lysosomal enzymes and free oxygen 
radicals. This is followed by the invasion of macrophages that phagocytose cell debris. 
Demyelination of white matter begins within 24 hours.  Small CSF filled cysts develop that 
are surrounded by demyelinated nerve fibres 
13, 14, 15
.  
Classification of Spinal Cord injury: The international standards for neurological 
classification of spinal cord injury provide a simplified universally accepted procedure for 
classifying spinal cord injury. The procedure involves systematic evaluation of dermatomes 
and myotomes. This also provides definition for complete and incomplete injuries. A 
complete injury is defined as an injury where there is lack of any sensory or motor function in 
the lowest sacral segment. An incomplete injury is where there is at least partial sensory or 
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motor function in the lowest sacral segment. The examination observes the evaluation of 
sensation at key sensory points and motor grading of key muscles representing myotomes. 
The neurological level of injury is the most caudal segment of the spinal cord with normal 
sensation and motor function bilaterally. This also includes a scale of impairment called 
American Spinal Injury Association Impairment scale (ASIA) which classifies SCI into five 
categories of severity, labelled A to E based on the degree of sensory and motor loss
16
.  
Persons with motor complete lesions have a poor prognosis for recovering ability to walk. 
Only 2-3 % persons classified initially as having an initial A convert to D.  Persons with 
preserved pin prick sensation in the lowest sacral dermatome has 70% chance of regaining 
ambulatory capacity by 1 year, while persons with  only light touch sensation in the same 
region are unlikely to regain ambulatory capacity
17
. The first step in the management of the 
person suspected to have sustained spinal cord injury is ensuring adequate air way, and 
immobilising the spine with a collar and spinal board before transporting to the medical 
facility. Once medically stabilised, Xrays , CT/MRI are done to assess the damage to bone 
and soft tissues. Closed reduction is performed by proper positioning and applying a series of 
increasing distracting forces. Surgical treatment of acute spinal cord injury is performed 
either to stabilise an unstable spine or to decompress any compressed natural elements. Role 
of surgery in complete lesions is to provide early stability and rapid involvement in of the 
injured person in rehabilitation. Pharmacological treatment of acute spinal cord injury 
includes high dose methyl prednisolone in the first eight hours of injury. This appears to 
interrupt the secondary injury cascade by inhibiting lipid per oxidation and reducing level of 
free radicals. This method as a standard of care is controversial because of concerns 
regarding methods of data analysis, choice of statistical methodology, randomisation 
imbalance, and inclusion of persons with minor motor deficits
18
.  
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Rehabilitation goals after spinal cord injury include maximization of physical independence, 
and preventing complications. The rehabilitation team includes family members of the person 
along with doctors, physiotherapists, occupational therapists, nurses, psychologists, social 
workers, recreation therapists, and vocational therapists. Physical and Occupational therapists 
train persons with spinal cord injury in mobility, self care skills, and other activities of daily 
living skills including wheel chair skills or ambulatory skills using orthotic support. Electric 
stimulation of nerves and muscles are commonly used for therapy, but can also be used to 
restore functions when it is referred to  as functional electrical stimulation. This can increase 
the muscle bulk, prevent pressure sores, prevent contractures, reduce osteoporosis, control 
spasticity, generate hand grip, improve bladder, bowel and sexual functions and enhance 
ambulation. A computer controlled functional electrical system is known as the 
neuroprosthesis
19
. 
 Spinal cord injury causes a surge of events that eventually leads to loss of the central part of 
the cord, leaving a rim of demyelinated axons in the periphery of the cord. The traditional 
approach had been to limit the damage, since it is easier to limit the progression of injury than 
to repair the damaged cord. Initial studies towards this direction used peripheral nerve grafts 
and transplanted cells to bridge the gap of injury (Intercostal nerves, Schwann cells). The 
axonal growth was not satisfactory in the hostile environment of the distal cord. Following 
the injury the condition triggers a train of secondary events that progressively destroy the 
tissue adjacent to the lesion over period hours to weeks. Major components of secondary 
mechanism include vascular effects, haemorrhage, ischemia, metabolic derangement, ionic 
changes, glutamate induced exicotoxicity, free radical excess, cytokines and chemokines and 
inflammation leading to apoptosis of neurons and oligodendrocytes. This leads to the 
formation of central cavity surrounded by astrocytic scar with a small rim of white matter 
with demyelinated non-conducting axons in the periphery of the injured spinal cord
20
.  
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Secondary injury cascade; dynamic changes following trauma showing initial  
hemorrhage progressing to cavity formation over time. 
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Cell based methods for spinal cord regeneration: 
Use of cell therapy to restore motor function following spinal cord injury is being persued 
extensively across the globe as a probable solution for this conundrum. The reports that have 
captured  scientific as well as media attention include transplantation of autologous olfactory 
ensheathing cells, foetal olfactory ensheathing cells, autologous activated macrophage 
transplantation, human embryonic cell derived pre-oligodendrocyte transplantation, and 
autologous bone marrow stromal cells transplantation which have entered initial clinical 
trials.  
 
1. Human oligodendrocyte progenitor from human embryonic stem cells: 
This method aims for remyelination of the preserved axons. Demyelination of spared axons is 
a prominent feature of spinal cord injury due to loss of oligodendrocytes. The initial insult is 
followed by a period of secondary degeneration characterized by oligodendrocyte death and 
subsequent demyelination of the axons. In order to address the demyelination in the clinical 
setting, human oligodendrocytes differentiated from embryonic stem cells are transplanted 
into rat models of spinal cord injury. These cells have demonstrated promising results in 
experimental models. High purity oligodendrocyte precursors were differentiated from 
human embryonic stem cells for transplantation. Oligodendrocytes provide trophic support 
for neurons and axons. Neuronal survival has been known to depend on factors that inhibit 
apoptosis.  Factors produced by oligodendrocytes have been shown to induce sodium channel 
clustering along the axon and promote axon maturation and stability. These cells integrated 
into white matter, differentiated into oligodendrocytes, formed compact myelin and promoted 
recovery of motion. This study has now entered into Phase I clinical trial. Remyelination 
restores saltatory conduction in axon and locomotor deficits
21
.     
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2. Autologous olfactory ensheathing cells: 
During development, pathway taken by the growing nerve fibres depends on a large number 
of positive and negative signals recognised by the growth cones. These signals are located on 
other elements like neuronal and glial cells whose orientation determines the route taken. 
Following injury, in addition to local effects of damage, oligodendrocyes die, astrocytes 
proliferate, microglia invade, and large cavities filled with fluid are formed. Even though the 
cut ends of the axon continue to sprout locally for a long time it is unable to grow out towards 
its target.  
Olfactory neuron
Basal 
cell
Mucosa Lamina propria Bulb
astrocytes
OEC
axons
Mitral 
cell
Olfactory nerve fibroblasts
Basal lamina
 
Axons of olfactory neurons ensheathed by OEC which integrates with astrocytes in CNS 
 
 
 18 
 
 The olfactory neurons are formed continuously throughout adult life. These nerves contain 
unique type of ensheathing cells, known as the olfactory ensheathing cells. This cell 
resembles a non myelinating Schwann cell but encloses a large number of axons. Cultured 
and transplanted OEC in spinal cord demonstrated that it allowed the axons to align and grow 
across the lesion into the distal part of the tract. The axons having crossed the bridge may 
synapse locally. The olfactory ensheathing cells form a continuous channel or conduit for the 
axons to grow unhindered by the local inhibitory influences. These channels are important for 
effective axonal regeneration
22, 23
. 
 The Olfactory ensheathing cell has properties of both Schwann cells and astrocytes, with a 
phenotype closer to Schwann cell. It exists both outside central nervous system (like 
Schwann cell) and inside (like astrocyte) and it is able to assist axonal growth throughout 
adult life
24
. The most pronounced difference between OEC and Schwann cells is in their 
ability to interact with astrocytes. It has been demonstrated that when Schwann cells make 
contact with astrocytes they form a distinct cellular boundary without mixing. OEC do not 
form a boundary and can migrate freely among the astrocytes,. OEC do not induce reactive or 
hypertrophic responses in astrocytes that occur with Schwann cells as measured by astrocyte 
size, expression of GFAP, and growth inhibitory molecules like chondroitin sulphate 
proteoglycans.  Thus axons are able to traverse the graft axon boundaries following OEC 
transplantation
25
. Following focal lesion of corticospinal tract in rats, transplantation of OEC 
led to a directed elongation of regenerated corticospinal axons across the lesion and into the 
distal white matter
26
. Following successful reports in animal models of spinal cord injury 
autologous transplantation was performed in a phase I clinical study which demonstrated 
clinical safety, but with no motor recovery
27
.  
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3. Foetal olfactory ensheathing cells: 
 Olfactory cells derived from foetal olfactory bulb has been cultured and transplanted in 
patients spinal cord injury and favourable outcome has been reported in large number of 
patients in China
28
.  
4. Schwann cells: 
It has been observed that intraspinal Schwann cell graft limit injury induced tissue loss and 
promotes axon regeneration and myelination and that this response can be improved by 
adding neutrotrophic factors or anti-inflammatory agents. Implantation of Schwann cells in 
rat models of spinal cord injury promotes regeneration of sensory axons. It has been observed 
that  Schwann cell transplantation did not cause the axons to cross the bridge of implanted 
tissue. Schwann cell transplantation needs to be combined with other interventions to modify 
the permissiveness of the graft cord interfaces to allow axonal growth. Neurotrophic factors, 
Brain Derived Neurotrophic Factors (BDNF), Neurotrophin- 3 , (NT-3) or high dose methyl 
prednisolone facilitated the axonal growth. In general, Schwann cell  implantation alone into 
the site is not sufficient to promote axonal response that could lead to biologically significant 
functional recovery. It has been observed that transplanted Schwann cells did not migrate into 
surrounding spinal nervous tissue and therefore cannot myelinate axons that have regenerated 
through and beyond the graft. It has been clear that the grafting Schwann cell alone will not 
result in substantial functional recovery and additional intervention need to be combined with 
Schwann cell based repair strategies. Approaches to obtain axonal growth include decreasing 
inhibitory nature of the scar, preventing axons from the recognising the inhibitory molecules, 
and facilitating intrinsic ability of the neurons. Regeneration of supra spinal axons beyond the 
intra spinal graft is essential to achieve the cortical control of motor function following spinal 
cord injury
29,30,31,32
.  
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5. Activated Macrophage transplantation: 
The concept of repairing the damaged spinal cord and the role of immune system has been 
investigated. In experimental animals with spinal cord injury, local injection of homologous 
macrophages induced partial recovery after their activation by incubation with autologous 
peripheral nerves.  Macrophages incubated with autologous skin as been found to be equally 
effective. The exposure of the macrophages to the injured regenerative tissue like the excised 
skin is thought to sensitise the macrophages towards a wound healing property. The skin     
co incubated macrophages have been reported to demonstrate a distinctive profile of cytokine 
secretion and cell surface markers. These cells have the potential to influence nerve cells 
immune cells and glial cells that are present in the injured spinal cord. In rat models of spinal 
cord injury, the skin activated macrophages promoted neurological recovery and reduced 
cavity formation. Unlike single molecule therapy, autologous macrophage therapy is intended 
to exploit the numerous activities that are characteristic of these cells including the clearance 
of tissue debris from the lesion site, secretion of protective and healing molecules and 
modulation of immune system. All these contribute to improved cell survival and regrowth
33
. 
A phase I clinical trial among 8 patients with spinal cord injury has been conducted. A single 
dose of 4 x10
6 
cells in 60µl were administered into spinal cord parenchyma at the lower 
border of the traumatic lesion. Three patients demonstrated partial recovery and the cell 
therapy were tolerated in these patients, and further clinical evaluation has been 
recommended.  Transplanted patients underwent preoperative and follow up neurological 
assessment according to American Spinal Injury Association scale, electrophysiological 
monitoring of motor evoked and somato sensory potential, magnetic resonance imaging and 
safety monitoring. The two main problems in arriving a conclusion from the results was a 
lack of control group and the small number of patient cohort
34
. 
 
 21 
 
 6. Neural stem cells: 
Recent observations have raised the possibility that the brain has inherent capacity for self –
repair in response to injury or disease through the use endogenous NSC or neural progenitor 
cells.  NSC in the adult brain is able give rise to neurons in few restricted areas in vivo like 
subventricular zone in the wall of the lateral ventricle and subgranular zone of the 
hippocampal dentate gyrus. Poor regenerative capabilities of adult CNS is due to inhibition 
by the microenvironment factors present in most areas of the central nervous system. The 
number of endogenous NSC will be too small for effective cell repair. Strategies to overcome 
these obstacles could facilitate recovery from damage.  In addition to micro environmental 
factors including cytokines and cell to cell interactions, fate of NSC or neural progenitor cells 
have been shown to be regulated by epigenetic modification of the cell specific genes through 
DNA methylation or chromatin structure. Neural stem cells have great potential as a 
therapeutic tool in a number of central nervous system disorders. However today little 
evidence exist regarding the efficacy of neural stem cells and restoring function. NSC can be 
isolated from embryonic or adult brain tissue. There are two major methods of applications 
for treatment of CNS disorders. First it can be transplanted as undifferentiated cells, whose 
subsequent differentiation could be controlled by signals derived from host CNS. 
Alternatively, NSC pre differentiated in vitro to desired neuronal cells which could be 
transplanted to host CNS. This is preferable as it has the ablility to direct the differentiation 
from stem cell to desired neuronal phenotype
35
. It appears that in vitro manipulation of NSC 
lineage fate prior to transplantation may be necessary to control terminal lineage of the 
transplanted cells. Although NSC exhibit remarkable degrees of plasticity with regard to 
lineage potential it may not be sufficient to overcome local barriers. Both embryonic and 
adult NSC differentiates into primary glia when transplanted into CNS. When pluripotent 
NSC  were transplanted into injured spinal cord, the engrafted cells differentiated only to 
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astrocytes. Hence successful neuronal replacement may require transplanting cells committed 
to neuronal lineage rather than pluripotent lineage. Pluripotent NSC differentiates into 
oligodendrocytes and form myelin after engraftment. When NSC are transplanted into 
contused rat spinal cord majority of cells differentiate into astrocyte with no 
oligodendrocytes. Hence to obtain large number of oligodendrocytes from transplanted NSC 
it will be necessary to initiate oligodendrocyte lineage commitment invitro prior to 
transplantation. Transplantation of this progenitor cells expressing immature oligodendrocyte 
markers, into spinal cord of myelin deficient rat resulted in large areas of myelination
36,37
.  
 
7.  Autologous bone marrow and Granulocyte macrophage colony stimulating factor: 
Transplanted bone marrow cells into the spinal cord models were found to improve 
neurological deficits in the central nervous system injury models by generating neural cells or 
myelin producing cells. Bone marrow cells can also produce neuroprotective cytokines, 
which rescue neurons from impending cell death after the injury. Granulocyte macrophage 
colony stimulating factor has been observed to improve neurological outcome.  Recombinant 
GM CSF has been used in patients with bone marrow suppression. It causes haemopoiesis by 
inducing the growth of several different haemopoeitic lineages. It also enhances the 
functional activities of mature effector cells involved in the antigen presentation and cell 
mediated immunity, including neutrophils,  monocytes, macrophages, and dendritic cells. It 
has been reported that GM-CSF has prevented apoptotic cell death not only in haemopoeitic 
cells but also in neuronal cells. GM-CSF stimulates microglia cells to increase brain derived 
neurotrophic factor and decreased the neuronal apoptosis and thus improving functional out 
come in animal models of SCI
38
. 
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 8. Autologous  Bone Marrow  Mesenchymal Stem Cells: 
Bone marrow provides a source of circulating erythrocytes, platelets, monocytes, 
granulocytes, and lymphocytes which are derived from haematopoietic stem cell.  The 
marrow stroma is complex tissue that contains cells that are required for lineage commitment 
for haematopoietic cells. Although initially considered to be primarily haematopoietic 
support cells, the marrow stromal cells also contain non haematopoietic cells that can 
differentiate into a variety of mesenchymal cells including bone, fat and cartilage. MSC is 
thus a unique cell in the bone marrow that differentiate into non haematopoietic and non 
lymphocytic tissues. The stromal cells have a propensity to adhere to tissue culture plastic, a 
property which has been used as a means to isolate them from bone marrow. MSC are thus 
pluripotent cells capable of differentiating into various mesenchymal tissues, like 
chondrocytes, osteoblasts, myoblasts and adipocytes. Several criteria are required for 
transplantation of MSC in humans like safety, reproducibility and quality. For clinical use it 
is necessary to find a method to amplify MSC in a short time retaining all the properties
39
.  
MSC are plastic adherent cells with multi potent differentiation capacity which express 
CD73, CD90, CD105, CD106, CD146and HLA ABC (MHC Class I), while being negative 
for CD34, CD45 and surface HLA DR(MHC Class II). Human serum does not support the 
growth of MSC in vitro. Platelet derived growth factor PGDF is observed to be a critical 
factor in growth supplementation. DMEM supplemented with fresh frozen plasma and 
platelets provide optimal growth conditions
40
. 
Because MSC are easy to isolate, and have broad differentiation potential and proliferate in 
vitro, they are attractive candidates for cell therapy. Bone marrow is an accessible source for 
these cells. Ideally the cell for transplantation should be autologous easily obtainable, and 
effective in supporting host axonal growth when placed in vivo. The ideal time for 
 24 
 
transplantation is the time after the initial inflammatory cascade has subsided and before the 
astrocytic scar is established. MSC transplanted into rat models have been observed to 
migrate towards the injury site. When MSC were transplanted 3 months after the injury, 
functional benefits were seen four weeks after transplantation which continued to one year. 
Grafted MSC formed cellular bridges across the cavity in the spinal cord and expressed 
astrocytic and neuronal markers
41
. 
It has been observed that these cells trans differentiate into neuronal lineage in vitro under 
specific conditions of inducing media. These findings have been controversial. It has also 
been suggested that they can form neural cells when exposed to CNS microenvironment. 
MSC form guiding strands for host axonal growth when transplanted to sites of spinal cord 
injury in rat models. In addition MSC establish a cellular matrix that support host axonal 
growth probably due to endogenous growth factor production by MSC
42
. MSC 
transplantation in spinal cord in rats can remyelinate the demyelinated spinal cord axons. 
Thus MSC has a potential to provide an efficient and renewable source of cells for auto 
transplantation at sites of demyelination or white matter diseases
43
.  
The use of autologous bone marrow has distinct advantages as it avoids problems associated 
with graft versus host interaction. Autologous bone marrow therapy is considered safe and 
not associated with malignancy potential. Extensive scientific data on previous experience in 
BMSC transplantation for haematological diseases are available which demonstrate safety. 
These advantageous make cell therapy using BMSC applicable and are being investigated for 
treatment of various neurological diseases. Bone marrow has a mixed cell population 
including hematopoietic stem cells, mesenchymal stem cells, endothelial progenitor cells, 
macrophages and lymphocytes. It has been observed that haemopoietic and mesenchymal 
stem cell has neuroprotective effect and permit neural growth
44, 45, 46
.  
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9. Adipose stem cell: 
Adult stem cells can differentiate appropriate neuronal phenotypes in damaged neuronal 
phenotype. Adipose tissue compartments are a particularly useful source of mesenchymal 
stem cells due to easy availability, clonogenic potential and robust proliferative capability. 
Adipose derived stem cell can differentiate into adipocyte, chondrocyte, myocyte, oesteoblast 
and also neural lineages. Adipose derived stem cells have therapeutic potential and functional 
recovery in rodent models of spinal cord injury in vivo have been reported after 
transplantation. Subcutaneous fat contains unpurified population of stem cells including 
adipose derived stem cells. The other cells include endothelial cells, smooth muscle cells, 
pericytes, fibroblast, leucocytes, haemopoietic stem cells or endothelial progenitor cells. 
Adipose derived stem cells are plastic adherent and thus the cells self select out of the mixed 
cell group during subsequent cell culture passages. When adipose derived stem cells were 
transplanted to animals with neural injury they migrated to the injured area and some cells 
stained positive for MAP-2, and glial fibrillary acidic protein
47,48,49
. 
 
Non cell based methods for spinal cord regeneration: 
These include a variety of agents which have been found to support axonal growth following 
spinal cord injury in experimental conditions. Minocycline, a tetracycline is observed to 
prevent secondary inflammatory cascade, resulting in  limited tissue damage.  Rolipram 
blocks the phospho diesterase enzyme in the axonal terminal end, increase the cyclic AMP 
and promote axonal linear growth.  Chondroitinase is a bacterial enzyme which lyses the 
proteoglycan scar formed by the astrocytes and facilitates the axonal regrowth.  
 
 26 
 
4-Aminopyridine: 
4-aminopyridine a potassium channel blocker, facilitate axonal conduction of the 
demyelinated axons. Toxins like charybdotoxin, BTK2 which are voltage gated potassium 
channel blockers can promote axonal conduction in demyelinated axons. Physical trauma to 
spinal cord results in demyelination of axons. Without insulating sheaths of myelin the 
surviving axons become less efficient to transmit electrical impulses. When the axons are 
demyelinated after injury large numbers of potassium channels which are juxtanodular at 
nodes of Ranvier are exposed and potassium ions leak out. 4-aminopyridine blocks this 
exposed potassium channels and restores the ability of the axons to transmit electrical 
impulses. Clinical studies using 4- aminopyridine demonstrated statistically significant 
improvement in reduction of spasticity and a positive trend towards improvement
50
.  
Sodium and potassium channel blockers: 
HP184 (N-proxyl, 3 Fluoro,4 pyridinyl,1H-3-Methyl indole-amine hydrochloride) 
pharmacological blocker capable of antagonising both sodium and potassium channels have 
been developed and is undergoing studies to evaluate the effect on spinal cord injury both on 
walking function and on spasticity. 
 GM-1 ganglioside: 
Mono sialo tetra hexosylganglioside GM-1 sodium salt is a naturally occurring compound 
which is located in the cell membrane of the neural cells. Preclinical studies demonstrating 
neuro protective and neuroregenerative actions by GM-1 in experimental models have been 
reported. Clinical trial showed variable outcome with no definitive conclusions
51
.  
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Minocycline: 
 Minocycline  is a broad spectrum of  antibiotic, a lipophilic derivative of tetracycline that has 
demonstrated ability to provide neuroprotection. Mechanisms attributed for protective actions 
elicited by minocycline include ability to overcome glutamate mediated exicitotoxicity, anti-
inflammatory effects by blocking the activation of microglial cells inhibiting Cytochrome C 
release, inhibiting caspase dependent apoptotic neuronal death and antagonising matrix 
metallo-proteases. Minocycline also reduces oligodendrocytes apoptosis and corticospinal 
tract die back in animal models of spinal cord injury
52
.  
Nogo: 
The   non-permissive environment for axonal growth is associated with oligodendrocytes and 
myelin. Monoclonal antibody directed against this substrate allowed the axonal out growth.  
Nogo is essential during development of the nervous system to permit and guide the axonal 
growth in a linear manner towards target.  
oligodendrocyte
Nogo 66 OMgp
MAG
Nogo receptor Co receptor p75
Rho
Growth cone collapse
Cyclic AMP
phosho diesterase
Inhibitors - rolipram  
Nogo receptors, molecular inhibitors and potential targets for treatment 
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 Nogo A is a high molecular weight transmembrane protein and potent inhibitor of neural 
growth, produced by oligodendrocytes. Efforts to develop antagonists to target Nogo receptor 
is being studied
53, 54
. It has been demonstrated that oligodendrocyte myelin membrane act as 
an inhibitor for axonal growth. The major inhibitory elements which have been suggested to 
block axonal growth include chondroitin sulphate proteoglycan, myelin associated 
glycoprotein, and oligodendrocyte myelin glycoprotein. Nogo receptor is part of a receptor 
complex on the axonal membrane, which act through Rho at growth cone. Growth cone 
cytoskeleton is composed of filamentous actin fibres with distinct features of distal finger like 
filapodia and central fan like lamella podia . Blockade of Rho by elevated levels of cyclic 
AMP prevents the growth cone collapse and facilitate axonal growth. Agents like Roliparam 
which blocks the phoshodiesterase enzyme cause elevation of cAMP allowing axons to grow.  
Methyl prednisolone: 
Methyl prednisolone sodium succinate was studied in NASCIS I, II and III . 
Methylprednisolone  elicits therapeutic effects due to improved protection from  ischemic 
insults and calcium dependent degradation of neurofilament cytoskeleton proteins. In the 
NASCIS trial, methylprednisolone was administered as 30mg/kg of bolus over the first hour 
followed by an infusion of 5.4 mg/kg per hour for the next 23 hours. An analysis of all 
patients failed to demonstrate significant differences. Analysis of data in the study showed 
the patient who received methylprednisolone within the 8 hours of injury significantly 
improved motor and sensory function compared to placebo. Despite beneficial therapeutic 
effects demonstrated with methylprednisolone treatment, results from this trial have not been 
universally accepted. Concerns due to small sample size of the population for the groups 
showing beneficial effects, non-standardised medical and surgical protocols by different 
participating centers and lack of correlation with functional outcome reduced the enthusiasm 
for administration methylprednisolone in acute spinal cord injury
55, 56
.  
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Materials & Methods 
All experiments were conducted with the approval from Institutional Review Board and the 
Animal Ethics Committee.  
Materials required: 
Cell culture facilities 
Phosphate buffered saline (PBS), Gibco,Catalog no: 10010. 
RosetteSep antibody cocktail, Stem Cell Technologies Inc, catalog. No: 15168. 
Ficoll-Paque, GE Healthcare Bio-Sciences, catalog .no: 17-1440-03. 
T75 culture flask, Greiner. 
Alpha - Minimum essential medium, Gibco, 
Fetal bovine serum, Gibco, catalog.no: 10082. 
L-Glutamine, Gibco, Catalog.no: 25030. 
0.25%Trypsin-EDTA, Gibco, Catalog.No: 25200. 
Dulbaco modified eagle medium, Gibco,catalog.No: 11995. 
DiMethylSulphoxide, DMSO Sigma, Catalog no: C6295 
Butylated hydroxyanisole (BHA), ACROS. 
Potassium chloride (Kcl) , Qualigens. 
Valproic acid, sigma, catalog. No:P4543. 
Forskolin, Sigma. 
Hydrocortisone, Sigma, catalog.No: H6909. 
Insulin, Sigma, catalog.No: I9278. 
bFGF, Invitrogen, catalog.no: 13256-029. 
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Hanks Balanced salt solution (HBSS), Gibco, catalog no: 14175. 
100U/mL penicillin, 100µg/ml streptomycin and 25ng/ml of amphotericin-B. 
Centrifuge, REMI. 
Laminar flow hood, Kartos International. 
CO2 incubator, Thermo Electron  Corporation. 
Inverted phase-contrast microscope. 
Animal experiments:  
Albio Wistar rats 
Animal house with air-conditioned facilities,  
Operation theatre for anaesthesia and surgery. 
 Ketamine 
Xylazine 
Operating microscope.  
Surgical instruments: 
Bone rongeur. 
 Surgical scissors. 
Equipment for drop weight device and transducers to record forces.  
 Transcranial cortical stimulator 
EMG recorder.  
Gait analysis set up for rats and video recorder for BBB score. 
3 D Injection device for cell transplantation. 
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Methods: 
i) Bone marrow collection: 
 Rat Bone marrow: 
              Male Albino wistar rat was weighed and anaesthetized with appropriate dose of 
Ketamine and Xylazine by intraperitoneal injection using 31-gauge insulin syringe. The hind 
limb was disarticulated at the hip joint and the muscles were cleared to expose the femur. The 
tibia and femur of rat were dissected. The femur was then isolated from the leg bones by 
incisions  at the knee joint. The ends of femur bone were opened  using bone rongeurs to 
expose the marrow cavity. A syringe containing a 2 ml of phosphate buffered saline (PBS) 
was inserted into the narrow cavity and the bone marrow was collected in a test tube by 
flushing the marrow cavity with phosphate buffer saline. The bone marrow suspension was 
then taken to the culture lab for processing. Procedures followed as described below.    
Isolation of Bone marrow stromal cells (BMSCs): 
        The mesenchymal stromal cells were separated from hematopoietic cells by using the 
Rosette Sep antibody cocktail. This cocktail cross links unwanted cells in bone marrow to 
multiple red blood cells (RBCs), forming immune rosettes. This increases the density of the 
unwanted (rosetted) cells, such that they pellet along with the free RBCs when centrifuged 
over a buoyant density medium such as Ficoll-Paque.  Desired cells are not labelled with 
antibody and are easily collected as a highly enriched population at the interface between the 
plasma and the buoyant density medium. 
                 2ml of bone marrow taken in a 15ml tube was incubated with Rosette Sep cocktail 
50µl/ml of bone marrow at room temperature for 20 minutes. Bone marrow was diluted twice  
its volume with PBS and layered gently on top of Ficoll-Paque taking care to minimize 
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mixing of both the sample and Ficoll-Paque.  The sample was then centrifuged at 1200 rpm 
for 25 minutes at room temperature and the enriched cells removed carefully from the (Buffy 
layer)  interface between the plasma and the Ficoll fluid. The enriched cells were washed in 
10ml PBS and centrifuged at 1000 rpm for 10 minutes at room temperature. The supernatant 
was discarded and cell pellet was dissolved in culture medium. 
Cell Counting: 
         10µl of cell sample was stained with 30µl of tryptan blue (ratio of 1:4) and charged into 
the counting chamber using micropipette. The cell viability and numbers were   calculated.   
Culture of MSC 
The cell  culture medium consisting of Minimum Essential Medium (MEM Alpha) (Gibco), 
supplemented with 20% fetal bovine serum (Gibco), 2mM L-glutamine (Gibco-Invitrogen), 
100U/mL penicillin, 100µg/ml streptomycin and 25ng/ml of Amphotericin-B. 30µl of the cell 
suspension was taken and mixed with 30µl of 0.4% trypan blue stain (Gibco). Viable cells 
were counted using haemocytometer under phase-contrast microscope and the number of 
cells/ ml was calculated. Approximately 8000 cells/cm
2 
were  plated on to polystyrene culture 
dishes (Greiner bio-one). The culture was maintained at 37°C, with 5% CO2 in air, at 95% 
humidity. The cells were fed every second day by replacing half of the culture medium with 
fresh complete medium. 
Characterization of cultured cells 
Monolayered cells grown on Poly-L-lysine coated cover slips were washed twice with PBS 
and fixed in 4% paraformaldehyde for 15 min. Fixative was removed by washing thrice in 
PBS. The cells were incubated in power block (proteinaceous blocking agent containing 
casein, PBS with 0.09% sodium azide) for 10 minutes at room temperature. This is to 
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minimize the non-specific binding of antibody to highly charged sites in the cover slips. The 
cells were then incubated with primary antibodies (i) for integrin β1 (rabbit polyclonal  
serum, 1:500 chemicon) and (ii) for CD54 (mouse monoclonal antibody, 1:100, Chemicon) 
(iii) for collagen type I (rabbit polyclonal antibody, 1:500, Chemicon) (iv) for CD14 (mouse 
monoclonal antibody, 1:1000, Chemicon) (v) for CD45 (mouse monoclonal antibody, 1:100, 
Chemicon), Neurofilament  (1:100 Millipore), Neuron specific enolase (1:100 Millipore), 
Tau protein (1:100 Millipore) at 37°C for 1hour in moist chamber.  Primary antibody was 
washed off with PBS and cells were treated with secondary antibody (Super Sensitive 
Polymer-HRP IHC Detection system (BioGenex, USA) for 30minutes at 37ºC. To detect the 
HRP, the cells were incubated with stable DAB substrate buffer containing peroxide and 
liquid DAB chromogen (3, 3’-diaminobenzidine), The insoluble, permanent brown 
precipitate of oxidized DAB in the cells demonstrated the presence of HRP and hence the 
binding of primary antibody to the antigen. After washing off the chromogen with water, the 
cells were counterstained with Delafield haematoxylin (Qualigens) to demonstrate the nuclei. 
The cover slips containing the stained cells were cleaned with xylene and mounted with DPX 
(Qualigens). 
Neuronal Induction: 
Cells were washed with PBS thrice and treated with pre-induction medium for 24 hours  
before induction. After adding induction medium morphological changes were analysed and 
stained for Tau protein, Neurofilament, Neuron-specific enolase for the confirmation of  
neuronal transdifferentiation. 
Pre-induction medium: 
DMEM, 1µM bFGF and 20% FBS. 
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Long-term neuronal induction medium: 
DMEM, 2%DMSO, 200µM BHA,10mM Kcl, 2mM valproic acid, 10µM Forskolin, 1µM 
Hydrocortisone, 5µM Insulin. 
Fabrication of impactor for Spinal Cord Injury in Rats 
A device was developed which would deliver a force which can be used to create contusion 
model of  spinal cord injury of the rat. Measures of evaluating this injury would also be used. 
 Rat models have been well accepted for studying spinal cord injuries since the pathological 
changes after injury is similar to that occurs in  human injured cord. A device which will 
make injuries on the rats reproducibly was fabricated. This is important so as to make 
uniform injuries so that the effects of the interventions can be observed easily. 
The weight-drop method is most widely used in spinal cord injury impactors. The basic 
concept is to drop a known weight from a known height onto the spinal cord. We have used 
this method for our impactor. The forces that usually correspond to a drop of a weight of 10 
gms from a height of 12.5 - 50 mm, producing a mild to severe injury. The forces that are 
delivered to the spinal cord is approximately 1-2 N. 
Description of the Impactor 
The salient features of the impactor that was developed are as follows: 
  a weight of 10 gms which can drop from up to a height of anywhere in between 2.5 
mm to 20cm the heights corresponding to moderate and severe injury, respectively. 
 the rod hits the spinal cord and retracts back after a fixed time (the retraction is 
effected by an electromagnet that is controlled by a micro-controller). 
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 The micro-controller uses the position sensed using a sensor (an inductance sensor) to 
control the retraction of the weight. 
 The position is recorded in an oscilloscope and the force is then calculated after 
transferring the data into the PC. 
A frame is provided which can be sutured to the back of the rat so that it does not move when 
the experiment is in progress. This keeps the distance of the falling height constant. 
 
 Schematic diagram of the apparatus for Spinal Cord Injury showing the impactor.  
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The guide is made of a long glass tube. The solenoid and the inductor for the position sensing 
is wound on it, both of which are connected to the control circuit in the adjacent box. The 
frame to which the rat is sutured is also shown. 
Position Sensing: The position sensing is done using a coil (the length of the coil, L = 10 
cms, the total number of turns, n ~ 400 turns) which makes an inductor. As the rod moves 
through this inductor the inductance changes. The inductor is connected in parallel to a 
capacitor making a tank circuit. The output is fed into a rectifier and the rectified signal is 
then fed into the micro-controller which reads the position and decides when the the solenoid 
should be pulled back. 
Retraction: The retraction is affected by a solenoid which is powered by a motor driver chip 
controlled by the micro-controller. The solenoid is wound on a core of 4 mm and is made of a 
coated wire of thickness 0.24 mm. The length of the solenoid is 10 cms and it has ~ 1600 
turns (there are four layers of winding, each layer having 400 turns). 
Though various designs were thought of for delivering the force, the weight-drop method was 
finally chosen owing to its simplicity and acceptability in the research community. A fixed 
weight dropping from a fixed distance would also give a very reproducible velocity-before-
contact and therefore, a reproducible force delivered to the spinal cord resulting in a 
reproducible injury. The major factors that would effect the extent of the injury would be, 
 the velocity of the rod before it hits the cord 
 the time of compression of the rod 
 the amount of compression of the rod 
Assuming that the mechanical properties of the spinal cord of various rats will be the same, 
controlling the first two parameters should afford reproducible injuries to the rats. The first 
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parameter, i.e. the velocity of the rod before it hits the cord is fixed as the distance the rod 
falls due to gravity will be the same and is given by, 
v= 2∗ g∗ h  
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The second parameter is controlled by the solenoid that pulls the rod after a fixed amount of 
time after impact. The solenoid is energized and the resulting magnetic field pulls the rod 
away from the spinal cord. The instant of time when the solenoid is energized is decided by 
the position sensing circuit.  The principle of the position sensing is to measure the change in 
impedance of a tank circuit formed by a capacitor in parallel to an inductor coil, inside which 
the rod that would strike the spinal cord would move. As the rod moves the inductance alters 
changing the impedance of the tank circuit. This was done mainly to reduce the noise in the 
calculation of the acceleration. Timing of signals are not disturbed using this formula. Notice 
that the acceleration peaks just before the retraction, corresponding to the rod hitting the 
spinal cord. At the same time the velocity also starts to increase in the positive direction 
(positive is defined as away from the ground). This  impactor developed for creating  spinal 
cord injury drops a weight of 10 gms from a height of anywhere between 2 cms to 20 cms. 
The position is sensed using a sensor that used change in inductance to calculate the change 
in position and recorded on an oscilloscope.  
c. 
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Animal Experiments 
       Female Albino Wistar rat, 100-300g in body weight were anaesthetised with ketamine 
and xylazine  (90:10 mg/kg ) administered intra peritoneally. The fur was shaved on the mid 
dorsal region and cleaned with Povidone – Iodine solution (7.5% w/v), finally with surgical 
spirit. Tega-derm applied over it, to prevent fur contamination during surgery. 2cm incision 
was made over the lower thoracic area,  muscle and connective tissue were bluntly dissected 
to expose the T9-T11 vertebrae. A T10 laminectomy was completed using a microsurgery 
bone rongeur, taking care not to damage the spinal cord. Drop-weight injury was performed, 
with  10g weight rod falling from 20cm height on the exposed spinal cord. Absorbable suture 
were used to ligate the incised muscle and skin. Meloxicam 1mg/kg as analgesic, 
Enrofloxacin 2.5mg/kg   as antibiotic, and Ringer lactate 5ml/100g were administered sub-
cutaneously as post-operative care. Animals had free access to food and water throughout the 
study. Bladder and bowel expressed as post-operative care. 
 Operation theatre set-up: 
 
The animals were anaesthetised by intraperitoneal injection of ketamine and xylazine. Sterile 
surgical instruments and operation set-up ready for laminectomy procedure. 
c. 
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Laminectomy & rat model for spinal cord injury: 
 
Dorsal side of anaesthetized rat was shaved and cleaned with povidione and surgical spirit. 
Tegaderm applied over it, to prevent fur contamination during laminectomy.   
 
 
 
Incision of skin, subcutaneous tissue and location of spinous process, Laminectomy done at  
T10 level, without damaging the spinal cord. 
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Spinal cord was exposed in order to create spinal cord injury by drop-weight device. 
 
 
 
Setup with the exposed rat spinal cord as the target. The guide glass-rod can be seen, with a 
portion of it wrapped in blue containing the solenoid coil. The red box in the foreground 
contains the electronics. 
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Transplantation 
Transplantation of BMSC: 
        Two to six weeks following the drop-weight injuries, rats were re-anesthetized 
(intraperitoneal ketamine/Xylazine: 90:10 mg/kg), and the original incision was re-opened 
and the dorsal laminectomy was extended to the T9-T11 vertebrae. Under a surgical 
microscope, scar tissue from the previous injured site was removed until  spinal cord tissue 
could be visualized. After removal of the scar tissue, the gap between the caudal and the 
rostral stumps was approximately 3mm in longitudinal extent. 
All injections were made with the aid of a sterile Hamilton syringe attached to a 
micromanipulator. 5-50µl of cells was injected at different sites. Routine post-operative care 
was given. 
 
Hamilton syringe is attached to micromanipulator, which can move up and down. Cells were 
transplanted intra-lesionally into the injured cord, as well as caudal and rostral to the 
injured site.  
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Magnified view of transplantation: 
 
 
Cells transplantation: 
 
 
S.No 
Test group (n=12) Control group (n=12) 
Duration 
between 
injury and 
gait (days) 
Duration 
between 
transplant 
and gait 
(days) 
Cell 
numbers 
(Lakhs) 
Pre-
transplant 
BBB 
Post 
transplant 
BBB 
Hindlimb 
EMG 
Amplitude 
Duration 
between 
injury and 
gait (days) 
BBB Hindlimb 
EMG 
Amplitude 
1 32 420 10.0 0 8 0.4687 323 1 - 
2 45 113 10.0 0 1 - 191 0 0.2734 
3 19 120 16.7 0 6 0.8593 144 1 0.2734 
4 14 111 11.5 0 7 0.6835 118 0 0.0976 
5 13 104 13.5 0 4 0.8203 106 2 0.0000 
6 26 79 13.3 1 5 0.9375 104 0 0.0585 
7 27 78 21.5 0 3 1.3378 101 0 0.0000 
8 30 75 16.2 0 2 0.2734 97 0 0.0000 
9 21 51 18.9 0 4 1.1328 87 1 0.1171 
10 17 53 24.0 0 6 1.7187 85 0 0.0000 
11 16 14 16.8 0 1 - 84 2 0.1171 
12 13 49 20.5 0 4 1.0351 72 0 0.0000 
 
 
Lateral side 
Cranial side 
Injecting needle 
Injured spinal cord is exposed in 
between lateral sides, on which the 
injecting needle is positioned for 
transplantation. 
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Postoperative care: 
  Following the surgery, rats were nursed  in cage and monitored until they recovered from 
anaesthesia. Rats were monitored twice a day throughout the post-injury survival period for 
general health and mobility. Bladders were manually expressed twice daily. Ringer lactate 
10ml was administered subcutaneously twice daily on the first 5-10 postoperative days. To 
prevent urinary tract infection, prophylactic antibiotics were administered (Enrofloxacin 
2.5mg/kg) once a day for first 10 postoperative days. Animals were monitored for urinary 
tract infections (UTI) for the entire period of the experiment. If an animal developed general 
debilitation, vaginal inflammation, or discharge indicative of a UTI, they were treated with 
the antibiotics. Inspection for skin irritation or decubitus ulcers or evidence of autophagia, 
was carried out daily. 
Behavioural assessment: 
             The BBB scale is an operationally defined 21-point scale, designed to assess hind 
limb locomotor recovery after impact injury to the thoracic cord in rats. This scale categorises 
combinations of rat hind limb joint movements, trunk position and stability, stepping, 
coordination, paw placement, toe clearance, and tail position, representing sequential 
recovery stages that rats attain after spinal cord injury. Open-field observations were made on 
rats placed in a floor area of 95×95cm. All rats received bladder expression before open field 
testing to eliminate behaviours due to bladder fullness.( Appendix: BBB Scale) 
Transcranial stimulation & Cortical evoked potential study for cord integrity  
                      Transcranial stimulation of motor cortex was done in the anaesthetized rats 
and the EMG signals were recorded from the upper limb and the lower limb muscles. 
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Among spinal cord injured rats which received MSC transplantation, EMG signals were 
observed in the lower limb muscles on stimulation of motor cortex. 
 
EMG study before cell transplantation (after injury) 
 
 
The upper wave of each set was collected from the upper limb (triceps muscle) and the 
lower wave from the lower limb (gastrocnemius) of the paraplegic rats.  
EMG recording 
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Statistical Analysis 
The data collected for BBB assessment and EMG were analyzed using Wilcoxon test and 
Mann – Whitney test.  P value < 0.05 was considered significant in this study. 
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Results 
Isolation of bone marrow mesenchymal cells:  
 Bone marrow mesenchymal stem cells were separated from rat bone marrow by ficoll-paque 
density gradient method. This yielded buffy coat as shown in the figure which was rich in 
mononuclear cells including BMSC.  
Haematopoietic
precursor cells
Ficoll Paque solution
Buffy  coat
 
Buffy coat cells on plating on to plastic culture dish in the culture media allowed BMSC to 
adhere to the plastic and grow and thus selectively separated these cells as seen in the figure. 
 
 48 
 
First day culture of Bone marrow stromal cells: 
 Culture on the first day showed rounded cells adherent to the plastic culture dish, a 
characteristic feature of the BMSC as seen in figure. 
 
Confluent culture of BMSC:  
Within two weeks the cells multipled and assumed confluence as seen in figure below. 
 
 
20X 
20X 
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Characterization of Mesenchymal stem cell: 
Mesenchymal stem cells are characterized by  positive cell markers which included  
antibodies directed against cell-surface molecules ( integrin  β1 and CD54) present on MSCs 
along with  extracellular matrix molecules (type I collagen) that are synthesized by cultured 
MSC.  As seen in the figure, two specific haematopoietic  cell surface markers, (CD14- 
present on leukocytes and CD45 – present on monocytes and macrophages) are not expressed 
on mesenchymal stem cells.   
 
 50 
 
     
a)  Confluent culture  b) Integrin β1  c) Collagen type I   d) CD54    e) CD14    f) CD45. 
b a 20x 
c d 
e f 20x 20x 
40x 40x 
40x 
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Neuronal induction of Bone marrow Mesenchymal Stem cells: 
                       It has been reported that rat and human MSCs retain the capacity to 
differentiate  into non-mesenchymal derivatives, specifically neurons. A simple treatment 
protocol has been described to induce the stromal cells to exhibit a neuronal phenotype 
expressing Neuron-specific enolase, Neurofilament, and Tau protein by Woodbury et al
57
 
which was conducted as a part of this study and the results are shown in the figures below. 
                      To initiate neuronal differentiation, neuronal induction media composed of 
DMEM, dimethylsulfoxide  (DMSO), butylated hydroxyanisole (BHA) was utilized. Long 
term neuronal induction media consisting of DMEM, DMSO, BHA, KCl, valproic acid, 
forskolin, hydrocortisone and insulin was used. 
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   After treatment with the medium for neuronal induction, morphology of cells was observed 
from 30 min to 180 min. Retraction of cell body and process elaboration is evident with 
increasing time. Processes continued to elaborate, displaying primary and secondary branches 
with  growth cone-like terminal expansions and filopodial extensions. 
 
 
 
 
 
 
30’ 
90’ 
120’  
150’ 
 
180’ 
60’ 
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Neuronal induction after 3hrs:
 
Neuronal induction after 24hrs: 
 
 
400X 
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Neuronal induction after 48 hrs: 
 
Neuronal induction after 72 hrs: 
 
 
 
 55 
 
Identification of Neuronal induced cells by neuronal markers: 
Tau protein immunostained: 
 
Neurofilament marker: 
 
Neuron-specific enolase marker: 
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 BBB motor score:  
 Hind limb movement of the transplanted rats progressed from 0 to maximum of 8 in BBB 
rating scale. In comparison of  control group, transplant group  rats improved in hind limb 
function, which is statistically significant (p<0.05), whereas control group did not show any 
progress indicating that there is no spontaneous recovery after spinal cord injury. Control 
group improved in BBB score maximum of 2, though statistically significant (p=0.035)  in 
comparison to that of before transplant group. 
Graph 1 BBB score of the  transplant group before and after cell transplantation. 
 
Table 2  BBB 
 Transplant group (n=12) Control group (n=12)  
P value Before transplant After transplant  
Mean 
 
SD Mean SD Mean SD 
Before 
transplant Vs 
control group 
 
0.083 
 
0.288 
   
0.583 
 
0.792 
 
0.108 
After 
transplant Vs 
Control 
group 
   
4.250 
 
2.261 
 
0.583 
 
0.792 
 
0.0001 
Before 
transplant Vs  
After 
transplant 
 
0.083 
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Cortical evoked potential: 
  Electromyographic signal was recorded using intra-muscular bipolar electrodes in triceps  
(forelimb) and soleus muscles (hind limb) by stimulating the motor cortex. On stimulation, 
the forelimb exhibits normal EMG pattern both in control and transplanted group since 
forelimbs are not involved in a T10 injury. EMG amplitude in hind limb muscles between 
control and transplanted group showed significant difference (p<0.001). 
50% of control rats exhibited no response in soleus on stimulation. There was no onset 
potential compared to transplanted group (p=0.053).This shows transplanted MSCs in the 
injured cord has a role in functional repair.  
 
Table 3 Electromyography  
 
 
 
Hind limb 
 Transplant group 
(n=10) 
Control group (n=11)  
P value 
Mean SD Mean SD 
Onset time 
(msec) 
0.032 0.021 0.013 0.016 0.052 
Peak time 
(msec) 
0.037 0.023 0.016 0.018 0.059 
Amplitude 
(mV) 
0.926 0.416 0.085 0.104 0.0001 
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Discussion 
The consequences following spinal cord injury are devastating affecting physical and  
emotional facets of life. The costs encountered by the individual are enormous, to address the 
medical, surgical and rehabilitative care as well as for social and vocational reintegration. 
Last decade has seen an aggressive pursuit to mitigate the cascade of problems following 
spinal cord injury to alleviate some of these difficulties, if not to offer cure. Several intense 
experimental studies are being conducted across the world, and some of them have found 
their way into initial clinical trials with promising results.  
Following spinal cord injury there is disruption of axons and damage to central gray matter 
and local haemorrhage. This primary event is followed by a complex cascade of chemical 
processes resulting in disturbances in local electrolyte homeostasis, high concentration of free 
radicals, excitotoxicity due to excitatory amino acids, local inflammation, regional hypoxia, 
and cellular apoptosis. The secondary mechanism damages the tissue that was spared during 
primary injury. This offers room for neuroprotective agents to reduce secondary damage, 
which has potential to change course of treatment of spinal cord injury in future. The 
secondary injury subsides over weeks and months following trauma. At the site of injury 
cellular reaction is represented by activation of astrocytes, microglia, macrophages, fibroblast 
and meningeal cell which together constitute the glial scar which is an impediment to neural 
regeneration.  The challenge at this stage is to promote axonal sprouting or remyelinate the 
preserved axons. Though several experimental approaches have been developed and 
published, an optimal strategy could be combinatorial treatment which addresses multiple 
barriers to neuronal regeneration
58
.  
Exciting reports have been published in literature regarding the use of cell therapy to restore 
motor function following spinal cord injury. The reports that have attracted wide scientific 
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attention include transplantation of autologous olfactory ensheathing cells, foetal olfactory 
ensheathing cells, autologous activated macrophage transplantation, human embryonic cell 
derived pre-oligodendrocyte transplantation, and autologous bone marrow stromal cells 
transplantation which have entered initial clinical trials.  
As discussed in review of literature, several studies reported favourable outcome following 
bone marrow stromal cell transplantation. However there are conflicting reports on the 
efficacy of MSC in spinal cord regeneration in experimental models following 
transplantation
59
. With these controversial data in literature, it was decided to observe the 
effect of bone marrow stromal cells for motor recovery following spinal cord injury in this 
study. 
  MSC have the advantage of being autologous and thus without ethical controversies. More 
over it obviates the need for immunosuppression following administration. Further, these 
cells are readily available as well as accessible, without causing any deficits in the donor 
tissue. Whole adult bone marrow contains a mixture of haemopoeitic cells including 
mononuclear cells like macrophages, and non haemopoeitic marrow stromal cells. MSC 
support the growth and differentiation of HSC ( haemopoeitic stem cells). MSC can be 
isolated by their ability to adhere to the plastic containers during tissue culture. MSC contain 
a population of cells that are self renewing and are capable of differentiating into mesodermal 
tissue, like bone, cartilage, fat, and muscle. In this study,  bone marrow from femur of adult 
male albino Wistar rat, were harvested, mesenchymal stem cells separated by ficoll-paque 
density gradient method, and cultured. The haemopoeitic fraction was separated by rosette 
cell separation. This was done to improve the population of mesenchymal stromal stem cells. 
The cultured cells were characterized by immunostaining techniques with specific markers 
which included beta 1- integrin, collagen1, CD54 positivity and negative for CD14 and 45.  
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These cells were then injected into experimentally induced spinal cord injured animal 
models.  
Different models of spinal cord injury could be created such as thermal injury, crush injury 
with aneurism clips, electro fulguration injury or radiation injury.  The model of injury 
chosen in this study was a drop weight contusion model, since this mirrors the type of injury 
that a human individual sustains following a fall or trauma. Contusion injury by drop weight 
method in female Albino Wistar rats was created which served as the animal model of spinal 
cord injury. The injury created was comparable as the force was measurable and the effects 
on the cord consistent, since a known weight was dropped from a known height and force 
was measured through a transducer. Cord injury was created at T9 /T 10 cord level following 
laminectomy as described  in literature. However maintaining a paraplegic rat is an intense 
and delicate task, since the rats are vulnerable for pressure sores, urinary tract infections, 
bladder calculi, and most of the complications that the human counterpart is also vulnerable 
to. The bladder needs to be emptied twice a day, and bowel once a day. Antibiotics need to be 
used judiciously and with caution. Hydration needs to be maintained and adequate supplies of 
nutrition ensured. The rats have to be nursed on a soft bed to prevent the pressures sores. 
Female albino wistar rats were chosen for the study, since management of bladder and related 
complications were easier to address than in the male rats. 
Rats were selected as the animal model because, the pathology following spinal cord injury is 
similar to human subjects. The central area of necrosis and fluid collection surrounded by 
demyelination of axons is similar to the pathology observed in human subjects;  hence,  an 
ideal model for intervention studies. Many experimental studies were conducted to find the 
optimal time for cell transplantation. To avoid destruction of transplanted cells by 
inflammatory processes in the acute phase, period between 10 to 14 days is considered 
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optimal for the transplantation. Animal studies show that significant gliosis is a major hurdle 
for axonal regeneration, in the chronic stage. 
The functional outcomes were measured by BBB score and EMG. BBB is a numerical motor 
scale, easy to perform, record, and compare. This scale measures the extent of movement of 
hip, knee and ankle by analysing the gait of the rat. The electrophysiological evidence of 
motor recovery was measured by transcranially stimulating the motor cortex using electrical 
stimulators and recording EMG from the gastrosoleus muscle. Eliciting wave forms in the 
calf muscle on stimulation of the cortex denotes  functional continuity of the cortico spinal 
tract. 
The rat models of spinal cord injury was considered in two group of twelve rats each. One 
group of rats received cell transplantation (transplant group, n=12) and the other did not have 
cell transplantation (control group, n=12).  Only rats with complete spinal cord injury was 
included in the study. Following the spinal cord injury the rats were observed for atleast for a 
period of two weeks before transplantation, to confirm completeness of the spinal cord injury. 
All the rats had the BBB score of 0 or 1.  This excludes the possible recovery due to 
preserved axons. This period also ensured that cells were not transplanted during the acute 
inflammatory phase, as  this could lead to loss of transplanted cells by reactive macrophages.  
A total cell dosage ranging from 10 to 24 lakhs were injected into the injured spinal cord at 
and around the site of contusion. Cells were administered at multiple sites as described in 
literature to ensure adequate cell delivery and minimize loss during injections.  Rats were 
followed up for a period ranging from two weeks to thirteen months. Post transplant BBB 
score showed improvement ranging from 1 to 8. Within the group which received 
transplantation, BBB motor score showed significant improvement (Graph 1) after 
transplantation (P=0.0001). In comparison with control group, transplanted group showed 
statistically significant improvement (P=0.0001). When the control group is compared with 
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pre-transplant group there is no significant change in motor score (P=0.108). These 
observations suggest motor recovery following cell transplantation.  The control group rats 
were followed up for a period of ten months and the BBB score did not reveal any 
spontaneous recovery in course of time.  
 In congruence to BBB, electrophysiological response in hindlimb of transplanted group also 
showed significant amplitude of the cortical evoked potential (P=0.0001) compared to control 
group. The transcranial electrical stimulation of the motor cortex of anaesthetised rats were 
performed in control and  transplanted group, and response recorded from the gastrosoleus 
muscles. This also demonstrated statistically significant change in amplitude among rats 
which received stem cell transplantation, indicating improved conduction as a factor for 
functional improvement. Remyelination of the demyelinated fibres from transplanted BMSC 
has been reported which contributes to the functional recovery. It has been observed that 
transplantation of bone marrow stromal cells can remyelinate the demyelinated spinal cord in 
animal models and the transplanted cells acted like the myelin forming cells as discussed 
earlier in the review of literature. 
Controversial results in the literature prompted the study to observe the trans-differentiation 
potential of bone marrow stromal stem cells. Woodbury et.al., reported that  bone marrow 
stromal stem cells on exposure to neuronal induction medium, rapid transdifferentiation of 
responsive cells occurred within 30 minutes to 180 minutes. Based on this interesting report  
the cultured bone marrow stromal stem cells was treated with the neuronal induction medium 
and morphological changes started appearing with in few minutes. The cytoplasm retracted 
towards the nucleus, forming a contracted multipolar cell body leaving membranous 
extensions in the periphery.  These cells assumed morphological characteristics of neural 
cells microscopically. Further it was also observed that these cells expressed neuronal 
markers, like neuron specific enolase, and neurofilament protein, and Tau protein suggesting 
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neuronal phenotype. Even though these results were similar to that have been described in 
literature it raises fundamental questions related to transdifferentiation . Mesenchymal 
stromal cells are mesodermal derivatives whereas neural tissue develops from ectoderm. Thus 
these findings though in congruence with the reported literature, are controversial. It has been 
suggested that the inducing medium shocks the cell organelles which retracts and deforms 
assuming a neural morphology.  It needs further corroboration with physiological tests using 
patch clamp techniques to demonstrate voltage-gated sodium channels on the cell membrane 
indicating exicitablitiy of the cell purporting neural transdifferentiation. Several studies has 
since been published refuting this ability of the mesenchymal stromal cell for neural 
transdifferentiation. It has been suggested that the morphological neuron like changes could 
be created by rapid disruption of actin cytoskeleton as a result of cellular toxicity. However, 
it is likely that these cells may differentiate in to neural cells or glia invivo in the spinal cord 
responding to molecular environment in the spinal cord
60
.  
Different routes of cell delivery have been described in literature. They include, direct 
injection to the cord after surgical exposure of the cord, or into the CSF ( cerebrospinal fluid) 
through a lumbar puncture, or intravenous stem cell infusion,  or administered by arterial 
cannualtion towards the anterior spinal artery . In this study the cells were delivered directly 
into the spinal cord as described in literature. The cord was re exposed and the injured 
segment received cells at multiple sites to reduce loss of cells during administration and avoid 
the controversies regarding homing of cells if provided through any other route.  The dose of 
cells administered varied from 10 to 24 lakhs to observe any dose response relationship. 
However no such direct relationship was seen. This could also be due to small number of rats 
in the study. 
 Transplantation of bone marrow stromal stem cells into injured spinal cord may provide 
therapeutic benefit. Although it has been suggested that differentiation of MSC into neural 
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lineage may occur in vitro and in vivo, it is unlikely to be a major factor in the functional 
recovery following spinal cord injury. Other mechanisms include neuroprotection, paracrine 
effects like expression of growth factors, cytokines, vascular factors, inhibition of apoptosis 
or remyelination. These may operate in parallel to contribute to the functional recovery. 
Potential advantages over other types of  cell transplants include their ability to be harvested 
from autologous donors and rapid expansion. Allogenic MSC are non immunogenic and can 
be readily available for clinical application. MSC lack B7 and co stimulatory molecules 
CD80 and CD86 and are non immunogenic on allogenic transplantation
61
.   
The host response to transplanted MSC is of critical importance. It has been demonstrated 
that MSC are capable of suppressing mixed lymphocytic reactions. Human MSC by virtue of 
their  distinct immune phenotype profile associated with the absence of  expression of HLA 
class II  and low expression of co stimulatory molecules are non immunogenic or hypo 
immunogenic. Allogenic MSC have many advantages in therapeutic application that it can be 
used even in acute setting. It has been reported that MSC even when delivered by intravenous 
infusion are capable specific migration into the injury. The mechanisms that guide of 
implanted cells could  be chemoattractive proteins on the injured cells. The undifferentiated 
cells delivered into injured host migrate to the site of injury and differentiate into the cells of 
appropriate phenotype under the influence of local signals. Homing is considered to be a 
coordinated, multistep process, which involves signalling by stromal-derived factor 1 (SDF-
1) and stem cell factor (SCF), activation of lymphocyte function-association antigen 1 (LFA-
1), very late antigen 4/5 (VLA-4/5) and CD44, cytoskeleton rearrangement, membrane type 1 
(MT1)-matrix  metalloproteinase (MMP) activation and secretion of MMP2/9. Rolling and 
firm adhesion of progenitors to endothelial cells in small marrow sinusoids is followed by 
trans-endothelial migration across the physical endothelium-extracellular matrix (ECM) 
barrier. Stem cells finalize their homing uniquely, by selective access and anchorage to their 
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specialized niches in the extravascular space of the endosteum region and in periarterial 
sites
62
.  
The findings of this study indicate that bone marrow stromal cells can be cultivated and 
maintained in culture easily in the culture lab which can be utilised for transplantation for 
spinal cord injury. The challenges of recovery due to transplantation of cells appears to be, 
cell survival, axon regeneration, and accurate targeting of the growing axons. 
The results demonstrated that the transplantation of bone marrow stromal stem cells in rat 
models of spinal cord injury at mid thoracic level led to moderate improvement in motor 
recovery as seen by behavioural analysis as well as by electrophysiological evaluation. 
Further studies in larger numbers with different dosages and different time since injury as 
well as combinatorial treatment with other agents will help to enhance the moderate recovery 
observed in this study.  
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Conclusions 
 
 Spinal cord injury results in permanent paralysis, loss of bowel and bladder control and other 
autonomic functions. Despite extensive research, there is no treatment available for this 
condition. This study demonstrated the role of bone marrow mesenchymal stem cells in 
spinal cord injury in rat models. 
1. Bone MarrowMesenchymal Stem Cells can be cultured from the bone marrow sample and 
can be characterised to be used for transplantation. 
2.Bone marrow Mesenchymal Stem Cells can be trans differentiated into neural cells in vitro 
using appropriate inducing media. However this observation needs further confirmation. 
3.Drop weight model of spinal cord injury gives a consistent comparable contusion model for 
research studies. 
4.Transcranial stimulation can be used to elicit motor evoked potential  to demonstrate 
functional continuity of corticospinal tract in rat models of spinal cord injury. 
5.Transplantation of bone marrow stromal stem cells can improve the motor out come in rat 
models of spinal cord injury as measured by BBB motor score and electrophysiological 
studies. 
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Recommendation for Future Studies 
1. Safety and and efficacy of MSC transplantation needs to be evaluated. 
2. The cell dosage of administration needs to be ascertained. 
3. The timing of cell transplantation after injury needs to be standardised. 
4. Frequency of administration for best response needs to be studied. 
5. The mechanism of action of MSC in spinal cord injury needs to be elucidated.  
6. The long term survival of MSC and integration into the host tissue needs study. 
7. The type of injury ( ASIA scale) where this will be most suitable needs confirmation. 
8. The homing mechanism of MSC needs further clarification.  
9.  The transdifferentiation of MSC into neural cells needs further verification. 
10.  Non invasive methods for tract tracing and cell tracking needs to be developed.  
 
 
 
 
 
 
 
 
 
 
 68 
 
BIBLIOGRAPHY 
1.Spinal Cord Injury Facts and Figures at a glance. Birmingham : National Spinal Cord Injury 
Statistical Centre 2004. 
2.Devivo MJ, Kartus PL, Stover SL, Fine PR,  Benefits of early admission to an organised 
spinal injury care system Paraplegia 1990; 23:545- 55.  
3.Mc Kinley W, Meade MA, Kirshblum S, Barnard B, Outcomes of early surgical 
management versus late or no surgical intervention after acute spinal cord injury. Arch Phys 
Med Rehabil 2004;85:1818-25. 
4. Pollard ME, Apple DF, Factors associated with improved neurological outcomes in 
patients with incomplete tetraplegia.  Spine 2003;28:39. 
5. Hall ED, Springer JE, Neuroprotection and acute spinal cord injury: A reappraisal. Neuro 
R 2004;1: 80-100.  
6. De Forge D, Nymark J, Lemaire E, Gardner S,Hunt M, MartelL, et al. Effect of 4 
aminopyridine on gait in ambulatory spinal cord injuries :a double blind placebo controlled 
cross over trial. Spinal Cord 2004;42: 674-85. 
7. T. M. Myckatyn, Susan E. Mackinnon, John W. McDonald Stem cell transplantation and 
other novel techniques for promoting recovery from spinal injury. Transplant Immunology  
2004: 12:343-358.  
8. Frank P. Barry.  Biology and Clinical applications of Mesenchymal Stem Cells, Birth 
Defects Research (Part C) 2003: 69:250-256. 
 
 69 
 
9. Gerald J Spangrude. Stem cells and tissue regeneration when is a stem cell really a stem 
cell? Bone marrow transplantation 2003: 32, s7-s11. 
10. DeVivo, MJ, Krause JS, Lammertse DP, Recent trends in mortality and causes of death 
among persons with spinal cord injury. Arch Physical Med Rehabil 1999; 80:1411-1419. 
11.Kandel E R, Schwartz J H,  Jessel T M,  Principles of Neural Sciences IV edition. 
12. White AA Panjabi MM. Clinical biomechanics of the Spine. 2nd Edition Philadelphia 
Lippencott-Raven;1990. 
13. Perry V, Andersson PB, Gordon S, Schwaab ME, BartholdiD.Macrophages and 
inflammation in the central nervous system . Trends Neurosciences 1993;16:268-273. 
14. Degeneration and regeneration of axons in the leisoned spinal cord. Physiol 
Rev1996;76:319-370. 
15. Young W, Koreh I Potassium and calcium changes in injured spinal cords. Brain Res 
1986;365:42-53 
16. American Spinal Injury Association. International standards for Neurological 
classification of spinal cord injury Chicago ASIA 2002. 
17. Marino RJ, Ditunno JF Jr, Donovan WH, et al  Neurological recovery after traumatic 
spinal cord injury ; data from the model Spinal cord Injury systems Arch Phys Med 
Rehabil.1999; 80:1391-1396. 
18.  Coleman WP, Benzel D, Cahill DW, et al. A critical appraisal of the reporting of the 
National Acute Spinal Cord Injury Studies II and III of methyl prednisolone in acute spinal 
cord injury. J Spinal Disorder 2000;13:185-199. 
 70 
 
19. Creasey GH, Ho CH, Triolo RJ, et al. Clinical application of electrical stimulation after 
Spinal cord injury. J Spinal Cord Med. 2004;27:365-75. 
20. A. Jane Roskams, Wolfram Tetzlaff. Directing stem cells and progenitor cells on the 
stage of spinal cord injury. Experimental Neurology.  2005:  193 267-272.  
21. Jill Faulkner, Hans S. Keirstead. Human embryonic stem cell-derived oligodendrocyte 
progenitor s for the treatment of spinal cord injury. Transplant Immunology 2005: 15131-
142. 
22.  FouladiNK, Li G, Raisman G. How do transplanted olfactory ensheathing cells restore 
function ? Brain Research Reviews. 2002;40:325-327.  
23. Li Y, Field PM, Raisman G. Olfactory ensheathing cells and olfactory nerve fibroblasts 
maintain continuous open channels for the growth of olfactory nerve fibres. Glia 2005;51 
24.  Alan Mackay Sim. Olfactory ensheathing cells and spinal cord repair. Keio J 
Med2005;54:8-14..  
25.  Fairless R, Barnett SC. Olfactory ensheathing cells: their role in central nervous system 
repair. The International Journal of Biochemistry and Cell Biology 2005:37; 693-699. 
26.  Raisman G. Olfactory Ensheathing Cells –another miracle cure for spinal cord injury  
Nature Reviews Neuroscience 2001;2:369-375.  
27. A Mackay Sim, Feron F, Cochrane J et al. Autologous olfactory ensheathing 
transplantation in human paraplegia: a 3 year clinical trial. Brain 2008;131:2376-2386. 
28.  Huang H, Chen L, et.al., Influence of patients' age on functional recovery after 
transplantation of olfactory ensheathing cells into injured spinal cord injury. Chinese Medical 
Journal 2003, 116 (10):1488-91.  
 71 
 
29. Schwann cells for spinal cord repair. Brazilian journal of biological research 2005; 
38:825-835.  
30. Basso DM , Beattie MS, Bresnahan  JC, Descending system to contributing  to motor 
recovery after mild or moderate spinal injury in rats , Experimental evidence and a review of 
literature 2002, 20:189-218. 
31. Xu XM, Guenard V, Kleiman N, Aebischer P & Bunge MB, A combination of BDNF 
and NT3  promotes supraspinal axonal regeneration into Schwann cell graft s in adult rat 
thoracic spinal cord.  
32. Pearse DD, Pereira FC, Marcillo AE, Bates ML, Berrocal YA, Filbin MT, Bunge MB 
cAMP and Schwann cell promote axonal growth and functional recovery after spinal cord 
injury, Nature Medicine 2004, 10:610-616. 
33  Bomstein Y, Marder JB, VitnerK, Smirnov I, Lisaey G, Butovsky O, et al. Features of 
skin co incubated macrophages that promote recovery from SCI. J. Neuro immunol  
2003;142:10-16. 
34. Knoller N , AuerbachD, Fulga V, ZeligG et al. Clinical experience using incubated 
autologous macrophages as a treatment for complete spinal cord injury: Phase I study results. 
J Neurosurg Spine2005; 3: 173-181. 
35. Okano H. Stem cell Biology of the cental nervous system, Journal of Neuroscience 
research 2002: 69:698-707. 
36. Cao Q, Benton RL, Whittemore SR. Stem cell repair of Central nervous system injury. 
Journal of Neuroscience Research 2002, 68:501-510. 
 72 
 
37. Keirstead HS, Blakemore WF, The role Oligodendrocytes and Oligodendrocyte 
Progenitor in CNS Remyelination .Adv Exp Med Biol 1999, 468:183-197. 
38. Ha Y, KimYS, Cho JM et al., Granulocyte macrophage colony stimulating factor (GM-
CSF) prevents apoptosis and improves  functional outcome in experimental spinal cord 
contusion injury. J Neurosurgery 2005: 11:55-61. 
39. MeulemanN, TondreauT, DelforgeA, DegeneffeM et al. Human marrow mesenchymal 
stem cell culture: serum free medium allows better expansion than classical alpha MEM 
medium. Eur J Haematol. 2006;76;309-316. 
40. Muller I, Kordowich S, Holzwarth C et al Animal serum free culture conditions for 
isolation and expansion of multipotent mesenchymal stromal cells from human bone marrow.  
Cytotherapy 2006;8(5): 437-444. 
41. Zurita M, VaqeroJ. Bone marrow stromal cells can achieve cure of chronic paraplegic 
rats; functional and morphological outcome  one year after transplantation.  Neuroscience 
Lett 2006;402:51-56. 
42.Lu P, Jones LL, Tuszynsky MH. BDNF expressing stromal cells  support extensive axonal 
growth at sites of spinal cord injury. Experimental Neurology2005;191:344-360. 
43. Akiyama Y, RadtkeC Kocsis JD Remyelination of rat spinal cord by transplantation of 
identified bone marrow stromal cells. Journal of Neuroscience 2002;22(15):6623-6630. 
44. Ankeny DP, Mc Tigue DM, Jakeman JB, Bone marrow transplant provide tissue 
protection and  directional guidances for axons after contusion spinal cord injury in rats. 
Exp.Neurology 2004; 190:17-31. 
 73 
 
 45.Chopp M, Zhang XH, Li Y, et al, Spinal cord injury in rat. Treatment with bone marrow 
stromal cell transplantation . . Neuroreport 2000;11:3001-3005. 
46. Yoon SH, Shim YS, Park YH, Chung JK et al. Complete spinal cord injury treatment 
using autologous bone marrow stem cell transplantation and bone marrow stimulation with 
granulocyte macrophage colony stimulating factor: Phase I/II clinical trial. Stem cells 
2007;25:2066-2073. 
47. Hak-Hyun Ryu, Ji-Hey Lim, Ye-Eun Byeon, Jeong-Ran Park, Min-Soo Seo, Young-Won 
Lee, Wan Hee Kim, Kyung-Sun Kang, Oh-kyeong Kweon. Functional recovery and neural 
differentiation after transplantation of allogenic adipose-derived stem cells in a canine model 
of acute spinal cord injury. Journal of Veterinary Science 2009, 10:4; 273-284.   
48. Lauren E.Kokai, B.S., J. Peter Rubin, M.D., Kacey G. Marra, The Potential of Adipose 
derived adult stem cells as a source of neuronal progenitor cells. Plast.Reconstr.Surg. 2005 
116: 1453. 
49. Kang  Sk, Shin MJ, Jung JS, Kim YG, Kim CH. Autologous adipose tissue derived 
stromal cells for treatment of spinal cord injury. Stem cells Dev 2006:15, 583-594. 
50. DeForge,D., Nymark J, Lemaire E, Gardiner S et.al., Effects of 4-aminopyridine on gait 
in ambulatory spinal cord injuries. A double blind placebo controlled cross over trial.  Spinal 
Cord 2004 : 42: 674-685.  
51. Gisler F H., Dorsey .F.C, Coleman W P., Recovery of motor functions after spinal cord 
injury; a randomised placebo controlled trial with GM-1 ganglioside  N.Engl. J  Med  1991 
324: 1829-1838. 
 74 
 
52. Stirling D P., Khodarahmi, K, Liu, J. Mc Phail L.T et.al Minocycline treatment reduces 
delayed oligodendrocyte death attenuated axonal die back and improves functional outcome 
after spinal cord injury. J.Neurosci. 2004 24:2182-2197. 
53. Walmsley, A.R, McCombie G, Neumann, U., Marcellin, D. et.al Zinc metalloproteases 
mediated cleavage of human Nogo 66 receptor. J Cell Sci 2004 117: 4591-4602. 
54. Li. S and Strittmatter  S.M. Delayed systemic Nogo 66 receptor antagonist promote 
recovery from spinal cord injury . J. Neurosci., 2003 23:4219-4227. 
55. Bracken M B, Shepard MG, Collins WF, Holford TR, Young W et.al Randomised 
controlled trial of methylprednisolone or naxolone in the treatment of acute spinal cord 
injury. Results of Second national acute spinal cord injury study N.Engl J Med. 1990 322: 
1405-1411. 
56. Hurlbert R J, Methylprednisolone for acute spinal cord injury: An inappropropriate 
standard of care. J. Neuro surg 2000 93: 1-7. 
57. Dale Woodbury, Emily J. Schwarz, Darwin J.Prockop, and Ira B.Black; Adult Rat and 
Human Bone Marrow Stromal Cells Differentiate into Neurons, Journal of Neuroscience 
Research 2000: 61; 364-370  
58. Kwon BK, Borisoff JF, Tetzlaff W. Molecular targets for therapeutic intervention after 
spinal cord injury. Mol Interv. 2002 jul; 2(4): 244-258 
59. Parr AM, KulbatskiI, Wang XH Keating A, Tator CH. Fate of transplanted adult 
stem/progenitor cells and bone marrow derived mesenchymal stromal stem cells in the 
injured adult rat spinal cord and impact on functional recovery. Surgical 
Neurology.2008;70:600-607. 
 75 
 
60. Lu P, Blesch A, Tuszynski MH. Induction of bone marrow stromal cells to neurons; 
differentiation, trans differentiation or artifact? J Neuroscience Research 2004;77:174-191. 
61. Parr AM, Tator CH, Keating A. Bone marrow derived mesenchymal stromal stem cells 
for repair of central nervous system injury. Bone Marrow Transplantation 2007;40:609-619. 
62. Tsvee Lapidot, Ayelet Dar, Orit Kollet How do stem cells find their way home? Blood 
2005: 106; 6, 1901-1910. 
 
 
 
 
 
 
 
 
 
 
 
